IRB Barcelona - Institute for Research in Biomedicine -ko ikertzaileekin lankidetzan egindako argitalpenak (15)

2023

  1. Inhibition of Prolyl Oligopeptidase Restores Prohibitin 2 Levels in Psychosis Models: Relationship to Cognitive Deficits in Schizophrenia

    International Journal of Molecular Sciences, Vol. 24, Núm. 7

  2. Pathogenic Mis-splicing of CPEB4 in Schizophrenia

    Biological Psychiatry, Vol. 94, Núm. 4, pp. 341-351

2021

  1. Adrenergic Modulation With Photochromic Ligands

    Angewandte Chemie - International Edition, Vol. 60, Núm. 7, pp. 3625-3631

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. Mutant HTT (huntingtin) impairs mitophagy in a cellular model of Huntington disease

    Autophagy, Vol. 17, Núm. 3, pp. 672-689

  4. P38γ and p38δ regulate postnatal cardiac metabolism through glycogen synthase 1

    PLoS Biology, Vol. 19, Núm. 11

2019

  1. Integrated analysis of germline and tumor DNA identifies new candidate genes involved in familial colorectal cancer

    Cancers, Vol. 11, Núm. 3

  2. Neuronal p38α mediates age-associated neural stem cell exhaustion and cognitive decline

    Aging Cell, Vol. 18, Núm. 6

2018

  1. Autism-like phenotype and risk gene mRNA deadenylation by CPEB4 mis-splicing

    Nature, Vol. 560, Núm. 7719, pp. 441-446

2017

  1. The prolyl oligopeptidase inhibitor IPR19 ameliorates cognitive deficits in mouse models of schizophrenia

    European Neuropsychopharmacology, Vol. 27, Núm. 2, pp. 180-191

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

  3. The metabolic co-regulator PGC1α suppresses prostate cancer metastasis

    Nature Cell Biology, Vol. 18, Núm. 6, pp. 645-656

2015

  1. Development of surface modified biodegradable polymeric nanoparticles to deliver GSE24.2 peptide to cells: A promising approach for the treatment of defective telomerase disorders

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 91, pp. 91-102

2014

  1. Differential neuroprotective effects of 5′-deoxy-5′- methylthioadenosine

    PLoS ONE, Vol. 9, Núm. 3